Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, ...
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- ...
SEOUL, South Korea and WELLINGTON, New Zealand, Feb. 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...
Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care SEOUL, South ...
- Lunit's strategic global leap: to acquire all of Volpara shares at AUD 1.15 per share, envisioning completion by Q2 2024 SEOUL. South Korea, Dec. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a ...
Lunit, a South Korean medical artificial intelligence (AI) startup, said Monday it has won shareholders' approval for the takeover of Volpara Health, a breast cancer solution firm in New Zealand. At a ...
(MENAFN- PR Newswire) WELLINGTON, New Zealand, Dec. 13, 2023 /PRNewswire/ -- Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX:VHT), a global leader in software for the early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results